Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SP1912 is a conserved protein antigen found in *Streptococcus pneumoniae*. It is a promising candidate for inclusion in pneumococcal protein-based vaccines due to its universal presence across global pneumococcal populations and its ability to elicit immune responses. While its precise biological function remains unknown, it is a highly conserved, immunodominant antigen, suggesting an essential role for bacterial physiology. It induces T cell responses, particularly Th17-type immunity, important for protection against colonization and invasive disease.
Induction of T cell (Th17) mediated immunity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae Protein Antigen SP1912 (SP1912).